Association Between Peanut Allergy and Asthma Morbidity
Objective
To evaluate the relationship between peanut allergy and asthma morbidity in school-age children.
Study design
The study involved a medical chart review to assess the association of peanut allergy with asthma morbidity in children beyond age 3 years. Peanut allergy was assessed by specific and validated criteria. A Poisson regression model was used to compare the frequency of systemic steroid use and of hospitalization for asthma beyond age 3 years in children with asthma with and without peanut allergy.
Results
Children with peanut allergy had a 2.32-times greater rate of hospitalization (P = .03) and a 1.59-times greater rate of systemic steroid use (P <.001) after controlling for covariates.
Conclusions
Peanut allergy serves as an early marker for asthma morbidity. Early prevention and intervention can improve quality of care.
CI, Confidence interval, ICAP RAST, ImmunoCAP radioallergosorbent test, NAEPP, National Asthma Education and Prevention Program, PPV, Positive predictive value, RR, Risk ratio, SPT, Skin prick test
The authors declare no conflicts of interest.
PII: S0022-3476(09)01215-3
doi:10.1016/j.jpeds.2009.11.080
© 2010 Mosby, Inc. All rights reserved.
